Alenvision Pharma Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2020.
2020 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Alenvision Pharma Private Limited

Alenvision Pharma Private Limited, a active private limited company, was established on 11 June 2020 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24100MH2020PTC340540. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.

It upholds a compliant status. Employing 89 professional, Its leadership includes Mandeep Singh (Director), Rajesh Kumar (Director). Past directors included Jitender Singh, Kuldeep Sandhu, Abhiraj Sandhu. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 216, Hi Tech Shopping Centre,, Near V.B. Nagar Police Station Kurla West,, Mumbai, Maharashtra, 400070.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100MH2020PTC340540

  • Registration Number

    340540

  • Incorporation Date

    11 June 2020

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹5.00 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 5.00 M
  • Company Age 5 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** -9.54%
  • Profit Growth **** -39.74%
  • Ebitda **** -429.67%
  • Net Worth 51.91%
  • Total Assets -1.85%
Company report

Alenvision Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Alenvision Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Alenvision Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Mandeep Singh Director 29 Mar 2024 Current
Rajesh Kumar Director 14 Aug 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 30 Mar 2024 Past
Pramod Abcsdd Director 14 Aug 2025 Past
Pramod Abcsdd Director 30 Mar 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Alenvision Pharma.

Alenvision Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.54% decrease. The company also saw a substantial fall in profitability, with a 39.74% decrease in profit. The company's net worth Soared by an impressive increase of 51.91%.

Alenvision Pharma revenue growth over time
Alenvision Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -9.54%
*******
*******
*******
*******
Revenue from Operations
*******
 -9.54%
*******
*******
*******
*******
Total Assets
*******
 -1.85%
*******
*******
*******
*******
Profit or Loss
*******
 -39.74%
*******
*******
*******
*******
Net Worth
*******
 51.91%
*******
*******
*******
*******
EBITDA
*******
 -429.67%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Alenvision Pharma?

Unlock access to Alenvision Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Alenvision Pharma?

Alenvision Pharma has a workforce of 89 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Alenvision Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alenvision Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Alenvision Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Alenvision Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Director Appointment

    Rajesh Kumar was appointed as a Director was appointed as a Director on 14 Aug 2025 & has been associated with this company since 7 months 15 days . was recorded as a recent event.

  • Balance Sheet

    Alenvision Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Progress on Mandeep Singh was appointed as a Director was appointed as a Director on 29 Mar 2024 & has been associated with this company since 2 years . was documented.

  • Company Incorporation

    The activity Alenvision Pharma Private Limited was registered on 11 Jun 2020 with Roc Mumbai & aged 5 years 9 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Alenvision Pharma Private Limited?

The CIN of Alenvision Pharma Private Limited is U24100MH2020PTC340540.

Where is Alenvision Pharma Private Limited headquartered?

Alenvision Pharma Private Limited is headquartered at 216, Hi Tech Shopping Centre,, Near V.B. Nagar Police Station Kurla West,, Mumbai, Maharashtra, 400070.

When was Alenvision Pharma Private Limited incorporated?

Alenvision Pharma Private Limited was incorporated on 11 June 2020.

Who are the current directors of Alenvision Pharma Private Limited?

The current directors of Alenvision Pharma Private Limited are

What is the primary industry of Alenvision Pharma Private Limited?

The primary industry of Alenvision Pharma Private Limited is Trade.

Is Alenvision Pharma Private Limited a listed company?

Alenvision Pharma Private Limited is unlisted.

What is the capital structure of Alenvision Pharma Private Limited?

The authorized capital of Alenvision Pharma Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.

What is the compliance status of Alenvision Pharma Private Limited?

The compliance status of Alenvision Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available